On the recordMarch 16, 2010
For seven plans we reviewed, the average negotiated price for the cancer drug Gleevec increased by 46 percent from about $31,000 in 2006 to more than $45,000 in 2009.
Source
congress.govFor seven plans we reviewed, the average negotiated price for the cancer drug Gleevec increased by 46 percent from about $31,000 in 2006 to more than $45,000 in 2009.
Bill Nelson highlights the significant price increase of the cancer drug Gleevec over recent years.
Share
More from Bill Nelson
Funding NASA is critical to getting back to the moon, advancing our scientific understanding, and driving innovation.
Look what happened when we spent the money on the Apollo program. Two generations of technology development came out of it.